BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kübler E, Albrecht H. Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines. Oncotarget 2018;9:24882-97. [PMID: 29861840 DOI: 10.18632/oncotarget.25427] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Rana A, Adhikary M, Singh PK, Das BC, Bhatnagar S. "Smart" drug delivery: A window to future of translational medicine. Front Chem 2022;10:1095598. [PMID: 36688039 DOI: 10.3389/fchem.2022.1095598] [Reference Citation Analysis]
2 Dahiya V, Bagchi G. Non-canonical androgen signaling pathways and implications in prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022;1869:119357. [DOI: 10.1016/j.bbamcr.2022.119357] [Reference Citation Analysis]
3 Morshed AKMH, Al Azad S, Mia MAR, Uddin MF, Ema TI, Yeasin RB, Srishti SA, Sarker P, Aurthi RY, Jamil F, Samia NSN, Biswas P, Sharmeen IA, Ahmed R, Siddiquy M, Nurunnahar. Oncoinformatic screening of the gene clusters involved in the HER2-positive breast cancer formation along with the in silico pharmacodynamic profiling of selective long-chain omega-3 fatty acids as the metastatic antagonists. Mol Divers 2022. [DOI: 10.1007/s11030-022-10573-8] [Reference Citation Analysis]
4 Suteau V, Munier M, Ben Boubaker R, Wery M, Henrion D, Rodien P, Briet C. Identification of Dysregulated Expression of G Protein Coupled Receptors in Endocrine Tumors by Bioinformatics Analysis: Potential Drug Targets? Cells 2022;11:703. [DOI: 10.3390/cells11040703] [Reference Citation Analysis]
5 Hozhabri H, Ghasemi Dehkohneh RS, Razavi SM, Razavi SM, Salarian F, Rasouli A, Azami J, Ghasemi Shiran M, Kardan Z, Farrokhzad N, Mikaeili Namini A, Salari A. Comparative analysis of protein-protein interaction networks in metastatic breast cancer. PLoS One 2022;17:e0260584. [PMID: 35045088 DOI: 10.1371/journal.pone.0260584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Pilch J, Kowalik P, Kowalczyk A, Bujak P, Kasprzak A, Paluszkiewicz E, Augustin E, Nowicka AM. Foliate-Targeting Quantum Dots-β-Cyclodextrin Nanocarrier for Efficient Delivery of Unsymmetrical Bisacridines to Lung and Prostate Cancer Cells. Int J Mol Sci 2022;23:1261. [PMID: 35163186 DOI: 10.3390/ijms23031261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Monfared RV, Alhassen W, Truong TM, Gonzales MAM, Vachirakorntong V, Chen S, Baldi P, Civelli O, Alachkar A. Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions. Cells 2021;10:2967. [PMID: 34831190 DOI: 10.3390/cells10112967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Freitas LF, Ferreira AH, Thipe VC, Varca GHC, Lima CSA, Batista JGS, Riello FN, Nogueira K, Cruz CPC, Mendes GOA, Rodrigues AS, Sousa TS, Alves VM, Lugão AB. The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers. Nanomaterials (Basel) 2021;11:2579. [PMID: 34685018 DOI: 10.3390/nano11102579] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Maiti KS, Fill E, Strittmatter F, Volz Y, Sroka R, Apolonski A. Towards reliable diagnostics of prostate cancer via breath. Sci Rep 2021;11:18381. [PMID: 34526529 DOI: 10.1038/s41598-021-96845-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chakraborty M, Hershfinkel M. Zinc Signaling in the Mammary Gland: For Better and for Worse. Biomedicines 2021;9:1204. [PMID: 34572390 DOI: 10.3390/biomedicines9091204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Proniewicz E, Burnat G, Domin H, Małuch I, Makowska M, Prahl A. Application of Alanine Scanning to Determination of Amino Acids Essential for Peptide Adsorption at the Solid/Solution Interface and Binding to the Receptor: Surface-Enhanced Raman/Infrared Spectroscopy versus Bioactivity Assays. J Med Chem 2021;64:8410-22. [PMID: 34110823 DOI: 10.1021/acs.jmedchem.1c00397] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Xu H, Sheng G, Lu L, Wang C, Zhang Y, Feng L, Meng L, Min P, Zhang L, Wang Y, Han F. GRPr-mediated photothermal and thermodynamic dual-therapy for prostate cancer with synergistic anti-apoptosis mechanism. Nanoscale 2021;13:4249-61. [PMID: 33595022 DOI: 10.1039/d0nr07196j] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Kumari N, Reabroi S, North BJ. Unraveling the Molecular Nexus between GPCRs, ERS, and EMT. Mediators Inflamm 2021;2021:6655417. [PMID: 33746610 DOI: 10.1155/2021/6655417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
14 Pilch J, Kowalik P, Bujak P, Nowicka AM, Augustin E. Quantum Dots as a Good Carriers of Unsymmetrical Bisacridines for Modulating Cellular Uptake and the Biological Response in Lung and Colon Cancer Cells. Nanomaterials (Basel) 2021;11:462. [PMID: 33670297 DOI: 10.3390/nano11020462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Perez Almeria CV, Setiawan IM, Siderius M, Smit MJ. G protein-coupled receptors as promising targets in cancer. Current Opinion in Endocrine and Metabolic Research 2021;16:119-127. [DOI: 10.1016/j.coemr.2020.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Abasian P, Shakibi S, Maniati MS, Nouri Khorasani S, Khalili S. Targeted delivery, drug release strategies, and toxicity study of polymeric drug nanocarriers. Polym Adv Technol 2021;32:931-44. [DOI: 10.1002/pat.5168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sorolla A, Sorolla MA, Wang E, Ceña V. Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment. Expert Opin Drug Deliv 2020;17:1597-613. [PMID: 32835538 DOI: 10.1080/17425247.2020.1814733] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Haider T, Pandey V, Banjare N, Gupta PN, Soni V. Drug resistance in cancer: mechanisms and tackling strategies. Pharmacol Rep 2020;72:1125-51. [PMID: 32700248 DOI: 10.1007/s43440-020-00138-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
19 Albrecht H, Kübler E. Systematic Meta-Analysis Identifies Co-Expressed Kinases and GPCRs in Ovarian Cancer Tissues Revealing a Potential for Targeted Kinase Inhibitor Delivery. Pharmaceutics 2019;11:E454. [PMID: 31480803 DOI: 10.3390/pharmaceutics11090454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sun C, Gu Y, Chen G, Du Y. Bioinformatics Analysis of Stromal Molecular Signatures Associated with Breast and Prostate Cancer.J Comput Biol. 2019;26:1130-1139. [PMID: 31180245 DOI: 10.1089/cmb.2019.0045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
21 Mero M, Asraf H, Sekler I, Taylor KM, Hershfinkel M. ZnR/GPR39 upregulation of K+/Cl--cotransporter 3 in tamoxifen resistant breast cancer cells. Cell Calcium 2019;81:12-20. [PMID: 31146164 DOI: 10.1016/j.ceca.2019.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
22 Insel PA, Sriram K, Gorr MW, Wiley SZ, Michkov A, Salmerón C, Chinn AM. GPCRomics: An Approach to Discover GPCR Drug Targets. Trends Pharmacol Sci 2019;40:378-87. [PMID: 31078319 DOI: 10.1016/j.tips.2019.04.001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 20.0] [Reference Citation Analysis]